Spark Alchemy Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 186.87%
- Profit Growth 113.38%
- Ebitda 76.63%
- Net Worth 2.62%
- Total Assets 11.30%
About Spark Alchemy
Spark Alchemy Private Limited (SAPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 November 2012 and has a history of 12 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Paresh Bagadia, Kaushik Mehta, and Manish Dharod serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100MH2012PTC237710
-
Company No.
237710
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Nov 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Spark Alchemy?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Paresh Bagadia
|
Director | 08-Nov-2012 | Current |
|
Kaushik Mehta
|
Director | 08-Nov-2012 | Current |
|
Manish Dharod
|
Additional Director | 18-Jul-2023 | Current |
Financial Performance of Spark Alchemy.
Spark Alchemy Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 186.87% increase. The company also saw a substantial improvement in profitability, with a 113.38% increase in profit. The company's net worth moved up by a moderate rise of 2.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spark Alchemy?
In 2022, Spark Alchemy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
P R Pharma Source Private LimitedParesh Bagadia and Kaushik Mehta are mutual person
-
Nixi Laboratories Private LimitedParesh Bagadia is a mutual person
-
Costcon Healthcare LlpParesh Bagadia is a mutual person
-
Apexio Pharma Private LimitedParesh Bagadia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Spark Alchemy?
Unlock and access historical data on people associated with Spark Alchemy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spark Alchemy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spark Alchemy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
